ASBP
Aspire BioPharma, Inc.
NASDAQ: ASBP · HEALTHCARE · BIOTECHNOLOGY
$0.22
-9.30% today
Updated 2026-04-30
Market cap
$1.03M
P/E ratio
—
P/S ratio
166.07x
EPS (TTM)
$-16.38
Dividend yield
—
52W range
$0 – $35
Volume
12.1M
Aspire BioPharma, Inc. (ASBP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-260.00 | $-1.41M | $-653107.00 | $-265186.00 | $-4.92M |
| Capital expenditures | $0.00 | $4.00 | $3.00 | $0.00 | $0.00 |
| Depreciation | — | $0.00 | $0.00 | $0.00 | — |
| Stock-based comp | — | — | — | $0.00 | $14.13M |
| Free cash flow | $-260.00 | $-1.41M | $-653110.00 | $-265186.00 | $-4.92M |
| Investing cash flow | — | $-294.69M | $284.92M | $13.78M | — |
| Financing cash flow | $260.00 | $296.59M | $-284.76M | $257645.00 | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |